Skip to Content

Opsumit 2.5 mg film-coated tablets

Licence status
Authorised: 19/09/2024
Active substances
Macitentan
Dosage Form
Dispersible tablet
Licence number
EU/1/13/893/004
Licence holder
Janssen Pharmaceutica NV

Licence information

ATC code
C02KX04 macitentan
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
19/09/2024